Zobrazeno 1 - 10
of 91
pro vyhledávání: '"ctace"'
Publikováno v:
Radiology and Oncology, Vol 57, Iss 1, Pp 70-79 (2023)
This trial aimed to compare the outcomes of drug-eluting beads transarterial chemoembolization (DEB-TACE) with CalliSpheres® microspheres (CSM) and conventional transarterial chemoembolization cTACE in the treatment of patients with unresectable hep
Externí odkaz:
https://doaj.org/article/a1b796c602134377aeea77fd78a56475
Autor:
Pi-Yi Chang, Rheun-Chuan Lee, Po-Chin Liang, Yi-Sheng Liu, Vicent P. Chuang, Ding-Kwo Wu, Yu-Fan Cheng, Jen-I. Huang, Hsiuo-Shan Tseng, Chien-Fu Hung, Reng-Hong Wu, Ming-Chih Chern, Hua-Ming Cheng, Chih-Horng Wu, She-Meng Cheng, Chia-Ling Chiang, Huei-Lung Liang
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Developed in early 1980s, transarterial chemoembolization (TACE) with Lipiodol was adopted globally after large-scale randomized control trials and meta-analyses proving its effectiveness were completed. Also known as “conventional TACE” (cTACE),
Externí odkaz:
https://doaj.org/article/de066f10aced450b8a15d098966866aa
Publikováno v:
Journal of Interventional Medicine, Vol 5, Iss 1, Pp 10-14 (2022)
Objective: To compare the safety of conventional transarterial chemoembolization (cTACE) vs drug-eluting bead TACE (DEB-TACE) in very early- and early-stage hepatocellular carcinoma (HCC). Methods: Data of patients with early- and very early-stage HC
Externí odkaz:
https://doaj.org/article/d2b4fb68b2d64c2485f239f1f9de1f88
Publikováno v:
Journal of Hepatocellular Carcinoma, Vol Volume 8, Pp 1459-1471 (2021)
Tao Ouyang,1,* Junxia Liu,2,* Chengyang Shi,3 Lisheng Zhu,4 Xiaopeng Guo1 1Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China; 2Cancer Medical Ce
Externí odkaz:
https://doaj.org/article/d35244ef9c7b42a7857fe47e9cd700b8
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
ObjectiveTo conduct a cost-effectiveness analysis of drug-eluting beads transcatheter arterial chemoembolization (DEB-TACE) and conventional transcatheter arterial chemoembolization (cTACE) for first-line treatment of hepatocellular carcinoma (HCC) f
Externí odkaz:
https://doaj.org/article/a4567cb252ed47e1b118d488230afcd9
Autor:
Guangxu Wei, Jijin Yang
Publikováno v:
Journal of Interventional Medicine, Vol 3, Iss 3, Pp 122-127 (2020)
Hepatocellular carcinoma (HCC) is one of the most common types of malignant tumor. Although radical surgery and liver transplantation are possible cures for the disease, most patients are beyond the optimum stage for radical treatment at the time of
Externí odkaz:
https://doaj.org/article/17d3eb3dff7547e1bf60dd928436ff21
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Hepatocellular Carcinoma, Vol Volume 9, Pp 27-28 (2022)
Ouyang T, Liu J, Shi C, Zhu L, Guo X. J Hepatocell Carcinoma. 2021;8:1459–1471. At the authors request, the Editor and Publisher of Journal of Hepatocellular Carcinoma wish to retract the published article. On review of the patient records the auth
Externí odkaz:
https://doaj.org/article/903a862670ad4ec3a33b360c39ec8fad
Publikováno v:
Journal of Hepatocellular Carcinoma
Tao Ouyang,1,* Junxia Liu,2,* Chengyang Shi,3 Lisheng Zhu,4 Xiaopeng Guo1 1Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Peopleâs Republic of China; 2Cancer Medical
Publikováno v:
Translational Cancer Research
Background This study aimed to evaluate whether corona enhancement and intratumor perfusion features of intra-procedural transcatheter intraarterial contrast-enhanced ultrasonography (IA-CEUS) predict short-term tumor response on follow-up contrast-e